Opendata, web and dolomites

InCa

InCa - Cardio Watch for Continuous Intra-Cardiac Blood Pressure Sensing

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 InCa project word cloud

Explore the words cloud of the InCa project. It provides you a very rough idea of what is the project "InCa" about.

spending    marketed    wirelessly    15    direct    cardiac    congestive    hospital    physician    energy    permanently    functions    stabilizing    chf    people    miniaturization    rate    biocompatibility    ultra    beginning    medicine    rehospitalization    incorporation    proprietary    time    medical    hospitalization    daily    hospitalizations    proactively    engineering    small    left    otherwise    3d    nano    patients    obesity    monitored    nanoprinting    business    progress    physicians    accounts    fabricated    disease    implanted    dramatically    proven    efficiency    micro    citizens    personalized    sports    admitted    profile    mobile    performance    first    sensor    24    pressure    technique    crisis    readings    vital    patient    die       outdoor    granular    wireless    background    trade    house    death    million    age    implant    ventricle    sense    treatments    continuous    population    healthcare    materials    monitor    atrium    medication    outstanding    65    normal    fabrication    output    sleep    backgrounds    lifetime    tweak    billion    heart    risk    readout    clock   

Project "InCa" data sheet

The following table provides information about the project.

Coordinator
EVOSENSE RESEARCH & DEVELOPMENT GMBH 

Organization address
address: RIEDLINGER STRASSE 21
city: DARMSTADT
postcode: 64283
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://www.cardio-watch.eu
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-12-01   to  2017-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EVOSENSE RESEARCH & DEVELOPMENT GMBH DE (DARMSTADT) coordinator 50˙000.00
2    NANOSCALE SYSTEMS, NANOSS GMBH DE (DARMSTADT) participant 0.00
3    TRINITAS VENTURES LIMITED IE (DUBLIN) participant 0.00

Map

 Project objective

Congestive Heart failure (CHF) affects more than 15 million European citizens and 1 in 5 people are at risk of developing CHF in their lifetime. It is the leading cause of hospitalizations in patients over 65 years of age, about 1 in 3 patients admitted to hospital will die within one year. CHF accounts for 1-2% (30 Billion €) of healthcare spending in Europe each year. The growth in the numbers of patients developing CHF is driven by the increasing age profile of the EU population and by the growing number of people developing obesity. Early death and rehospitalization can be reduced dramatically, when the progress of the heart disease is monitored continuously with a wireless pressure sensor, permanently implanted in the patient’s left heart ventricle or left atrium. The implant can provide physicians with detailed real-time information about the patient’s vital functions (intra-cardiac pressure, cardiac output and heart rate) around the clock. Based on those readings, the physician can proactively direct the patient to tweak the medication for stabilizing intra-cardiac pressure and provide early personalized treatments to avoid a crisis that would otherwise lead to hospitalization or even death. No mobile system is available, which allows to continuously and wirelessly monitor the patient’s vital functions during normal daily activities, e.g. (house-)work, sports or outdoor use or during sleep time. With the strong backgrounds in medicine, medical technology, nano- and micro fabrication as well as engineering and business background of the consortium the first, ultra-small cardiac pressure sensor implant for mobile, continuous 24-7-readout is investigated to be marketed beginning in phase III. One key for success is the incorporation of novel and proven nano-granular materials, which will be fabricated using a proprietary 3D nanoprinting technique (Nano-3D-Sense™) allowing for outstanding performance in miniaturization, biocompatibility and energy efficiency.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INCA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INCA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

SUPPLEPRINT (2018)

Super Productive Line Printing Inkjet

Read More  

HelpingHAND (2018)

A 3D printed, affordable myoelectrical prosthetic hand of personalizeable size for optimal comfort and functionality

Read More  

Volumizer (2018)

A natural, non-surgical, and safe facial filler which treats the root cause of facial ageing.

Read More